These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34449129)

  • 61. Microemulsion-based novel transdermal delivery system of tetramethylpyrazine: preparation and evaluation in vitro and in vivo.
    Zhao JH; Ji L; Wang H; Chen ZQ; Zhang YT; Liu Y; Feng NP
    Int J Nanomedicine; 2011; 6():1611-9. PubMed ID: 21904451
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Practical considerations for optimal transdermal drug delivery.
    Durand C; Alhammad A; Willett KC
    Am J Health Syst Pharm; 2012 Jan; 69(2):116-24. PubMed ID: 22215357
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Innovations in transdermal drug delivery: formulations and techniques.
    Tiwary AK; Sapra B; Jain S
    Recent Pat Drug Deliv Formul; 2007; 1(1):23-36. PubMed ID: 19075872
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cell-penetrating peptides as a novel transdermal drug delivery system.
    Nasrollahi SA; Taghibiglou C; Azizi E; Farboud ES
    Chem Biol Drug Des; 2012 Nov; 80(5):639-46. PubMed ID: 22846609
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Engineering approaches to transdermal drug delivery: a tribute to contributions of prof. Robert Langer.
    Mitragotri S
    Skin Pharmacol Physiol; 2013; 26(4-6):263-76. PubMed ID: 23921113
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A commentary on transdermal drug delivery systems in clinical trials.
    Watkinson AC
    J Pharm Sci; 2013 Sep; 102(9):3082-8. PubMed ID: 23468246
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Modeling the human skin barrier--towards a better understanding of dermal absorption.
    Jepps OG; Dancik Y; Anissimov YG; Roberts MS
    Adv Drug Deliv Rev; 2013 Feb; 65(2):152-68. PubMed ID: 22525516
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Age-related percutaneous penetration part 2: effect of age on dermatopharmacokinetics and overview of transdermal products.
    Konda S; Meier-Davis SR; Cayme B; Shudo J; Maibach HI
    Skin Therapy Lett; 2012 Jun; 17(6):5-7. PubMed ID: 22735504
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Recent advances in transdermal drug delivery.
    Subedi RK; Oh SY; Chun MK; Choi HK
    Arch Pharm Res; 2010 Mar; 33(3):339-51. PubMed ID: 20361297
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Topical and Transdermal Delivery of Drug-Loaded Nano/ Microsystems with Application of Physical Enhancement Techniques.
    Borgheti-Cardoso LN; Ângelo T; Gelfuso GM; Lopez RF; Gratieri T
    Curr Drug Targets; 2016; 17(13):1545-59. PubMed ID: 26477464
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A systematic review of medication administration errors with transdermal patches.
    Lampert A; Seiberth J; Haefeli WE; Seidling HM
    Expert Opin Drug Saf; 2014 Aug; 13(8):1101-14. PubMed ID: 24921682
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Microneedle integrated transdermal patch for fast onset and sustained delivery of lidocaine.
    Kochhar JS; Lim WX; Zou S; Foo WY; Pan J; Kang L
    Mol Pharm; 2013 Nov; 10(11):4272-80. PubMed ID: 24044683
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Challenges and opportunities in dermal/transdermal delivery.
    Paudel KS; Milewski M; Swadley CL; Brogden NK; Ghosh P; Stinchcomb AL
    Ther Deliv; 2010 Jul; 1(1):109-31. PubMed ID: 21132122
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Microneedles: a valuable physical enhancer to increase transdermal drug delivery.
    Escobar-Chávez JJ; Bonilla-Martínez D; Villegas-González MA; Molina-Trinidad E; Casas-Alancaster N; Revilla-Vázquez AL
    J Clin Pharmacol; 2011 Jul; 51(7):964-77. PubMed ID: 21148047
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs.
    Anjani QK; Permana AD; Cárcamo-Martínez Á; Domínguez-Robles J; Tekko IA; Larrañeta E; Vora LK; Ramadon D; Donnelly RF
    Eur J Pharm Biopharm; 2021 Jan; 158():294-312. PubMed ID: 33309844
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Fabrication, Physicochemical Characterization, and Performance Evaluation of Biodegradable Polymeric Microneedle Patch System for Enhanced Transcutaneous Flux of High Molecular Weight Therapeutics.
    Shah V; Choudhury BK
    AAPS PharmSciTech; 2017 Nov; 18(8):2936-2948. PubMed ID: 28432615
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Phospholipid and menthol based nanovesicle impregnated transdermal patch for nutraceutical delivery to diminish folate and iron deficiency.
    Kumari D; Bhatia E; Awasthi L; Banerjee R
    Biomed Mater; 2022 May; 17(4):. PubMed ID: 35168221
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmaceutical jewelry: Earring patch for transdermal delivery of contraceptive hormone.
    Mofidfar M; O'Farrell L; Prausnitz MR
    J Control Release; 2019 May; 301():140-145. PubMed ID: 30876952
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In Depth Analysis of Pressure-Sensitive Adhesive Patch-Assisted Delivery of Memantine and Donepezil Using Physiologically Based Pharmacokinetic Modeling and in Vitro/in Vivo Correlations.
    Mittapelly N; Pandey G; Tulsankar SL; Arfi S; Bhatta RS; Mishra PR
    Mol Pharm; 2018 Jul; 15(7):2646-2655. PubMed ID: 29856631
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Approaches for breaking the barriers of drug permeation through transdermal drug delivery.
    Alexander A; Dwivedi S; Ajazuddin ; Giri TK; Saraf S; Saraf S; Tripathi DK
    J Control Release; 2012 Nov; 164(1):26-40. PubMed ID: 23064010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.